Tuberous sclerosis genes regulate cellular 14-3-3 protein levels.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2003-12-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BBRC.2003.10.170PMID 14680818
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumour suppressors hamartin and tuberin: intracellular signalling.

  2003cited by this paper
• Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38

  2003cited by this paper
• 14-3-3β Binds to and Negatively Regulates the Tuberous Sclerosis Complex 2 (TSC2) Tumor Suppressor Gene Product, Tuberin*

  2003cited by this paper
• Regulation of PCNA and CAF-1 expression by the two tuberous sclerosis gene products.

  2003cited by this paper
• Akt-dependent Phosphorylation of p27Kip1Promotes Binding to 14-3-3 and Cytoplasmic Localization*

  2002cited by this paper
• 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s).

  2002cited by this paper
• Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling

  2002cited by this paper
• TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

  2002cited by this paper
• 'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments.

  2002cited by this paper
• Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.

  2002cited by this paper
• Identification and Characterization of the Interaction between Tuberin and 14-3-3ζ*

  2002cited by this paper
• Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling.

  2002cited by this paper
• Akt regulates growth by directly phosphorylating Tsc2

  2002cited by this paper
• Tuberous sclerosis complex tumor suppressor–mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent

  2002cited by this paper
• Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

  2002cited by this paper
• Evidence for Separable Functions of Tuberous Sclerosis Gene Products in Mammalian Cell Cycle Regulation

  2002cited by this paper
• Regulation of TSC2 by 14-3-3 Binding*

  2002cited by this paper
• 14-3-3 Proteins: Active Cofactors in Cellular Regulation by Serine/Threonine Phosphorylation*

  2002cited by this paper
• Tuberous sclerosis gene products in proliferation control.

  2001cited by this paper
• Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression

  2001cited by this paper
• Proteomics: Current technologies and applications in neurological disorders and toxicology

  2001cited by this paper
• 14-3-3 proteins and growth control.

  2000cited by this paper
• The TSC1 gene product, hamartin, negatively regulates cell proliferation.

  2000cited by this paper
• Molecular genetic advances in tuberous sclerosis

  2000cited by this paper
• Association of the Cyclin-dependent Kinases and 14-3-3 Sigma Negatively Regulates Cell Cycle Progression*

  2000cited by this paper
• The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho

  2000cited by this paper
• Reliable automatic protein identification from matrix‐assisted laser desorption/ionization mass spectrometric peptide fingerprints

  1999cited by this paper
• A Novel NE-dlg/SAP102-associated Protein, p51-nedasin, Related to the Amidohydrolase Superfamily, Interferes with the Association between NE-dlg/SAP102 and N-Methyl-d-aspartate Receptor*

  1999cited by this paper
• Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2.

  1998cited by this paper
• Identification of proteins by matrix-assisted laser desorption ionization-mass spectrometry following in-gel digestion in low-salt, nonvolatile buffer and simplified peptide recovery.

  1997cited by this paper
• Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.

  1997cited by this paper
• Effect of protein application mode and acrylamide concentration on the resolution of protein spots separated by two‐dimensional gel electrophoresis

  1997cited by this paper
• Role of the Tuberous Sclerosis Gene-2 Product in Cell Cycle Control

  1997cited by this paper
• Vertebrates have conserved capping protein α isoforms with specific expression patterns

  1997cited by this paper
• Vertebrates have conserved capping protein alpha isoforms with specific expression patterns.

  1997cited by this paper
• Identification and characterization of the tuberous sclerosis gene on chromosome 16

  1993cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Exploring 14-3-3ζ: insights into its role in cancer mechanisms and future therapeutic applications.

  2026cites this paper
• Epileptic Phenotype and Cannabidiol Efficacy in a Williams–Beuren Syndrome Patient With Atypical Deletion: A Case Report

  2021influential citation
• Primary Cilia as a Possible Link between Left-Right Asymmetry and Neurodevelopmental Diseases

  2017cites this paper
• Posttranscriptional regulation of 14‐3‐3ζ by RNA‐binding protein HuR modulating intestinal epithelial restitution after wounding

  2016cites this paper
• Targeting the PI3K-AKT-mTOR signaling network in cancer

  2013cites this paper
• 14-3-3 zeta as novel molecular target for cancer therapy

  2012cites this paper
• 14-3-3 zeta

  2011cites this paper
• Tandem affinity purification and identification of the human TSC1 protein complex.

  2010cites this paper
• Papel de la vía fosfatidilinositol 3 kinasa (PI3K/Akt) en humanos

  2009cites this paper
• Role of phosphatidylinositol 3-kinase pathway (PI3K/Akt) in humans

  2009cites this paper
• Association of TSC1/hamartin, 14-3-3sigma, and p27 expression with tumor outcomes in patients with pTa/pT1 urothelial bladder carcinoma.

  2008cites this paper
• Genotype–phenotype correlations in tuberous sclerosis: Who and how to treat

  2006cites this paper
• mTOR and cancer: insights into a complex relationship

  2006cites this paper
• Isoform‐ and subcellular fraction‐specific differences in hippocampal 14‐3‐3 levels following experimentally evoked seizures and in human temporal lobe epilepsy

  2006cites this paper
• 14-3-3 proteins in cell cycle regulation.

  2006cites this paper
• 14-3-3 proteins as potential oncogenes.

  2006cites this paper
• Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2

  2005cites this paper
• Clinical and molecular insights into lymphangioleiomyomatosis.

  2005cites this paper
• Downregulation of 14-3-3σ in ovary, prostate and endometrial carcinomas is associated with CpG island methylation

  2005cites this paper
• 14-3-3 proteins—an update

  2005cites this paper
• Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery

  2005cites this paper
• Inhibitors of the mammalian target of rapamycin

  2005cites this paper
• The Role of TSC1 in the Formation and Maintenance of Excitatory Synapses

  2005cites this paper
• Tuberous Sclerosis Complex: mutations, functions and phenotypes

  2005cites this paper
• The cellular response to ectopic overexpression of the tuberous sclerosis genes, TSC1 and TSC2: a proteomic approach.

  2005cites this paper
• Protein profile of the HeLa cell line.

  2004cites this paper
• Protein levels of alpha1-tubulin, protein disulfide isomerase, tropomyosins and vimentin are regulated by the tuberous sclerosis gene products.

  2004cites this paper
• Anabolic and catabolic signals

  2001cites this paper